FAST NEWS: Akeso raises $247 million through share placement
The Latest: Akeso Inc. (9926.HK) announced Sunday it has entered into placement agreements to issue 31.7 million shares to six investors priced at HK$61.28 per share, representing a 4.99% discount…
Innovent Bio hopes for plus-sized profits from obesity drug
The biopharmaceutical company reported a surge in half-year revenues but logged a bigger net loss, as investors look ahead to the launch of its new weight-loss drug Key Takeaways: Sales…
Recent Articles
RELATED ARTICLES
-
Test results for new cancer drug take Akeso investors on wild ride
9926.HK -
Akeso marks profit milestone with swift rights issue
9926.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
-
Clinical trials come up short again for Alphamab Oncology
9966.HK
-
Junshi hopes new scientist CEO can cure its woes
1877.HK 688180.SHG
